Sorafenib for treatment of hepatocellular carcinoma: a systematic review. [electronic resource]
Producer: 20120711Description: 1122-9 p. digitalISSN:- 1573-2568
- Antineoplastic Protocols
- Benzenesulfonates -- administration & dosage
- Carcinoma, Hepatocellular -- complications
- Cell Proliferation -- drug effects
- Chemoembolization, Therapeutic -- methods
- Hand-Foot Syndrome
- Hepatitis, Viral, Human -- complications
- Humans
- Liver -- metabolism
- Liver Cirrhosis -- complications
- Liver Neoplasms -- complications
- Neovascularization, Pathologic -- drug therapy
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Protein Kinase Inhibitors -- administration & dosage
- Pyridines -- administration & dosage
- Randomized Controlled Trials as Topic
- Receptor Protein-Tyrosine Kinases -- metabolism
- Sorafenib
- Treatment Outcome
- raf Kinases -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Review; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.